A3373 increased the level of active caspase-3 and decreased the levels of Ki67 and CD31, suggesting that A3373 enhances apoptosis and reduces both proliferation and tumor angiogenesis in cancer cells (Fig. 6e). This evidence concerns the gene PECAM1 and cancer.